Register Cart 0

Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back Subscribe

Editorial [Hot Topic: New Developments in the Prevention and Treatment of Vascular Disease - 2 Executive (Guest Editors: Manfredi Rizzo and Dimitri P. Mikhailidis)]

Author(s): Manfredi Rizzo and Dimitri P. Mikhailidis

Volume 17, Issue 33, 2011

Page: [3608 - 3610] Pages: 3

DOI: 10.2174/138161211798220990

Next »

Rights & Permissions Print Cite

Article Metrics

18

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Central Blood Pressure and Prediction of Cardiovascular Events
Current Hypertension Reviews

The Adipose Tissue as a Source of Vasoactive Factors
Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Personalized and Participatory Medicine as a Future Tool to Combat Cardiovascular Disease in Developing Countries
Current Pharmacogenomics and Personalized Medicine

The Role of Inhibitors in Hemostasis: A Comparison Between Neonates and Adults
Vascular Disease Prevention (Discontinued)

Physical Activity and Hypertension: Evidence of Cross-Sectional Studies,Cohort Studies and Meta-Analysis
Current Hypertension Reviews

The Mechanisms Responsible for Garlic - Drug Interactions and their In Vivo Relevance
Current Drug Metabolism

EDITORIAL: Different Aspects of Early Vascular Aging in Hypertension
Current Hypertension Reviews

Novel Nanostructured Polymeric Carriers to Enable Drug Delivery for Cardiovascular Diseases
Current Pharmaceutical Design

Is the Carotid Plaque Rupture a Pivotal Event in Stroke Pathogenesis? Update on the Role of the Intraplaque Inflammatory Processes
Current Vascular Pharmacology

Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease
Current Pharmaceutical Design

Calcium Channel Blockers in Obesity-Related Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)

Editorial [Hot Topic: Perspectives in Integrin Blocking (Executive Editor: C. Marcinkiewicz)]
Current Pharmaceutical Design

Perinatal Heart Programming: Long-term Consequences
Current Medicinal Chemistry

Editorial: Vascular Calcification, Cardiovascular Risk and microRNAs
Current Vascular Pharmacology

Potent and Orally Bioavailable Antiplatelet Agent, PLD-301, with the Potential of Overcoming Clopidogrel Resistance
Letters in Drug Design & Discovery

Classical and New Renin-Angiotensin Signalling in Atherosclerosis
Current Signal Transduction Therapy

C-Reactive Protein and Atherosclerosis: An Update
Vascular Disease Prevention (Discontinued)

Targeting the Platelet Integrin GPIIb/IIIa
Current Pharmaceutical Design

Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence
Current Pharmaceutical Design

Secondary Stroke Prevention in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Vascular Disease Prevention (Discontinued)

© 2024 Bentham Science Publishers | Privacy Policy